The Lattice (Official 3DHEALS Podcast)

3DHEALS
  • 5.0 (2)
  • Life Sciences
  • Updated Biweekly

Welcome to the Lattice podcast, the official podcast for 3DHEALS. This is where you will find fun but in-depth conversations (by founder Jenny Chen) with technological game-changers, creative minds, entrepreneurs, rule-breakers, and more. The conversations focus on using 3D technologies, like 3D printing and bioprinting, AR/VR, and in silico simulation, to reinvent healthcare and life sciences. This podcast will include AMA (Ask Me Anything) sessions, interviews, select past virtual event recordings, and other direct engagements with our Tribe.While there is no rule for our podcast content, the only rule we follow is to provide our listeners with a maximized return on their attention and time investment.Follow us on Facebook, Twitter, and Instagram @3dheals, and check out the links in the show notes. 3DHEALS Links: https://linktr.ee/3dheals 🛑 Disclaimer The content of this podcast is for informational and educational purposes only and does not constitute medical, legal, or financial advice. The views and opinions expressed by the host and guests are their own and do not necessarily reflect those of their employers, affiliates, or any associated organizations. While we discuss emerging technologies in healthcare and 3D printing, listeners should consult qualified professionals before making decisions based on the information shared. The mention of specific companies, products, or technologies does not imply endorsement. This podcast may reference early-stage innovations and concepts that are not yet FDA-approved or commercially available. Always follow regulatory guidelines and ethical standards when applying new technologies in clinical or professional settings.

  1. 3d ago

    Episode#126| Biomaterials Frontier for Medical 3D Printing (Virtual Event Recording)

    The real frontier in medical 3D printing isn't the printer — it's the material. In this 3DHEALS panel, five researchers, founders, and industry leaders map the shift from printing structure to printing function, and from lab-stage novelty toward regulated, investment-grade material systems spanning soft bioresins, bioactive ceramics, and titanium lattices. Fabian Trumper (Arrakis Bio) argues that the best biomaterials are the ones our bodies already make, and explains how his team bio-manufactures True Human Collagen at industrial scale. Prof. Kamal Choudhary (Johns Hopkins) shows why AI is reshaping materials discovery — a "ChatGPT for materials scientists" — and why so much of the field still isn't reproducible. Dr. Andrew Weems (Resilient Medical) shares how a 3D-printed scaffold could finally modernize lumpectomy surgery for breast cancer patients. Ebrahim Yarali (MERLN, Maastricht University) reveals how geometry alone — architected "meta-biomaterials" and 4D printing — can steer stem cells toward bone or cartilage. And Dr. Scott Taylor (Poly-Med) breaks down absorbable polymers that dissolve into the body once healing is done. Moderated by Craig Rosenblum, President of Himed. In this episode: Human vs. synthetic biomaterials — and what cells actually "notice"AI-designed materials and the reproducibility crisisDesigning devices for the surgery we already do4D printing and geometry as a biological signalA live debate: can AI and lab models replace animal testing?Whether you're a researcher, founder, or investor, this is a fast, opinionated tour of where medical materials are heading next. 🎥 Watch the full session and explore more 3DHEALS events: https://3dheals.com/biomaterials-frontier/ 00:00:00 - Welcome And 3D Heals Missions 00:01:58 - Event Setup And Sponsor Context 00:04:08 - Absorbable Polymers And Degradation Design 00:10:07 - Pore Size And Surface Area Effects 00:12:40 - True Human Collagen For Regeneration 00:23:08 - Collagen Q&A On Regulation 00:28:58 - AI Tools For Materials Discovery 00:41:35 - AI Limits Data And Loop Closure 00:50:31 - Lumpectomy Scaffolds And Go To Market 01:01:47 - Academia Versus Startup Mindset 01:10:13 - Geometry Driven Bone Regeneration Scaffolds 01:24:11 - Acoustic Responsive And 4D Biomaterials 01:31:08 - Panel Debate On Animal Testing 01:37:39 - AI Hype Real Impact And Wish List 01:46:51 - Final Takeaways And Closing Send us Fan Mail Support the show Subscribe to our premium version and support the show.  Follow us: Twitter  Instagram Linkedin 3DHEALS Website Facebook Facebook Group Youtube channel About Pitch3D

    Episode#126| Biomaterials Frontier for Medical 3D Printing (Virtual Event Recording)

  2. Sep 3

    Episode 125| Inside Tech Transfer At UCLA From Patents To Patients

    A single university discovery can turn into a life-changing therapy, but only if someone can translate the science into a product, a company, and a development plan investors will actually fund. That is why we sat down with Mark from UCLA’s technology transfer and licensing team to demystify what happens after the lab result and before the biotech headline. We talk plainly about what a tech transfer office does, what it can license, and why “intellectual property” now stretches beyond patents into data, materials, and even carefully governed patient datasets. We also zoom out to the policy foundation that made modern university commercialization possible: the Bayh-Dole Act. Mark explains how shifting IP ownership from the federal government to universities changed licensing outcomes and helped build the innovation ecosystem we now associate with US leadership in therapeutics. Along the way, we connect the dots to real UCLA impact, including major prostate cancer drugs and a licensed cure for ADA-SCID, and we unpack the tension founders often feel when a faculty inventor becomes a startup founder negotiating with their own campus. Then we get tactical. We break down why big pharma often waits until risk is reduced, why faculty-led startups become the bridge, and how license strategy changes depending on whether you are building a therapeutic that needs exclusivity or a platform that benefits from nonexclusive access. Mark walks through diligence milestones, annual progress reporting, and the practical reality that most “shelving” is not malicious, it is a startup fighting for survival. If you care about biotech startups, university patents, and the future of the Los Angeles bioscience ecosystem, this conversation is a roadmap. If this helped you see tech transfer differently, subscribe, share the episode with a founder or researcher, and leave a review telling us what part of the university-to-startup journey you want us to unpack next. Show notes: coming soon YouTube: coming soon Send us Fan Mail Support the show Subscribe to our premium version and support the show.  Follow us: Twitter  Instagram Linkedin 3DHEALS Website Facebook Facebook Group Youtube channel About Pitch3D

    Episode 125| Inside Tech Transfer At UCLA From Patents To Patients

  3. Aug 20

    Episode#123| Bioprinting In Microgravity with Dr. Michael Roberts ISS/CASIS

    Gravity shapes every lab workflow we take for granted, and it may be the hidden constraint behind some of the hardest problems in regenerative medicine. We sit down with Dr. Michael Roberts, a microecologist who led bioregenerative life support research at NASA’s Kennedy Space Center and now serves as Chief Scientific Officer of the International Space Station National Laboratory, to talk about what microgravity is actually good for and why biomanufacturing in space is no longer just sci-fi. YouTube: Pending Show notes: Pending Send us Fan Mail Support the show Subscribe to our premium version and support the show.  Follow us: Twitter  Instagram Linkedin 3DHEALS Website Facebook Facebook Group Youtube channel About Pitch3D

    Episode#123| Bioprinting In Microgravity with Dr. Michael Roberts ISS/CASIS

  4. Aug 7

    Episode #122| The Mini Brain That Learned Pac-Man: NAMs with Dr. Lowry Curley

    A brain organoid that can learn to play Pac-Man sounds like a stunt until you realize what it represents: measurable learning, rewiring, and human-relevant neural function that animal models often fail to predict. We talk with Dr. Lowry Curley, founder of Luna LifeSci and former CEO and co-founder of Axosim (now 28 Bio), about why neuroscience drug development breaks so often and how NAMs are finally giving teams better tools to make safer calls earlier. If you’re building in biotech, investing in drug discovery, or just trying to understand what replaces animal testing next, this conversation gives you a clear map of the technology, the incentives, and the milestones to watch. Subscribe, share this with a colleague, and leave a review with the biggest NAM question you want answered next. Show notes: https://3dheals.com/episode-122-new-approach-methodologies-nams-with-dr-lowry-curley/ YouTube: https://youtu.be/suVxiYZgPVE Send us Fan Mail Support the show Subscribe to our premium version and support the show.  Follow us: Twitter  Instagram Linkedin 3DHEALS Website Facebook Facebook Group Youtube channel About Pitch3D

    Episode #122| The Mini Brain That Learned Pac-Man: NAMs with Dr. Lowry Curley

  5. Jul 30

    Episode #121| Absorbable Biomaterials with Dr. Rao Bezwada

    Absorbable biomaterials have transformed modern medicine, enabling implants, sutures, and drug-delivery systems that safely degrade once their function is complete. Dr. Rao S. Bezwada has helped shape the field of bioresorbable polymers for more than three decades. As the inventor of Monocryl®, the absorbable suture that has generated more than $2 billion in worldwide sales, and the holder of more than 150 U.S. patents, his innovations have influenced everything from surgical sutures to next-generation biomaterials. In this episode of The Lattice, Dr. Bezwada joins Dr. Jenny Chen to discuss the science behind bioresorbable polymers, the chemistry that controls how materials degrade, and what the next generation of resorbable biomaterials could make possible. ⚠️ Disclaimer: This podcast is for educational and informational purposes only. The views expressed do not constitute engineering, medical, or financial advice. The technologies and procedures discussed may not be commercially available or suitable for every case. Always consult with a qualified professional. YouTube video:  Show notes: https://3dheals.com/episode-121-absorbable-biomaterials-with-dr-rao-bezwada/ Send us Fan Mail Support the show Subscribe to our premium version and support the show.  Follow us: Twitter  Instagram Linkedin 3DHEALS Website Facebook Facebook Group Youtube channel About Pitch3D

    Episode #121| Absorbable Biomaterials with Dr. Rao Bezwada

  6. Jul 16

    Episode #119 | 3D Printing At The Dentist with Dr. Nabeel Cajee

    If you have ever wondered why dentistry can feel both high-tech and oddly hand-built at the same time, this conversation connects the dots. We talk with Dr. Nabeel Cajee, an oral implantologist in Newport Beach and faculty at Torque Academy and Implant Ninja School, about what it really takes to bring digital dentistry into daily patient care without turning your practice into a science project. From the earliest days of open-source 3D printing to today’s clinical workflows, he breaks the ecosystem down into what actually matters: data capture, dental CAD design, and fabrication with dependable post-processing. If you care about dental 3D printing, chairside CAD/CAM, guided implant surgery, or the future of restorative dentistry, subscribe, share this with a colleague, and leave a review with your biggest question about digital workflows. Show notes: https://3dheals.com/episode-119-where-is-dental-3d-printing-with-dr-nabeel-cajee/ YouTube Video: https://youtu.be/FOKQNpMJjb4?si=DImMXMXEiNH5oheH Send us Fan Mail Support the show Subscribe to our premium version and support the show.  Follow us: Twitter  Instagram Linkedin 3DHEALS Website Facebook Facebook Group Youtube channel About Pitch3D

    Episode #119 | 3D Printing At The Dentist with Dr. Nabeel Cajee

  7. Jun 21

    Episode#117| Monica Wellejus:The Road to 3D-Printed Bone

    Ossiform is on track to bring the first 3D printed resorbable bone implant to the US market. The company’s preclinical data showed full bone regeneration in six months. Monica Wellejus, Chief Commercial Officer of Ossiform, joins The Lattice to explain how a company built to personalize bone implants for craniomaxillofacial surgeries is pivoting to mass-produced bone implants for foot deformity, and why hospital finance teams, not just the surgeons, may decide whether this technology actually reaches patients. ⚠️ Disclaimer: This podcast is for educational and informational purposes only. The views expressed do not constitute engineering, medical, or financial advice. The technologies and procedures discussed may not be commercially available or suitable for every case. Always consult with a qualified professional 00:00 Intro | Why 3D printed bone has not reached patients yet 02:08 Meet Monica Wellejus and Ossiform 05:41 How Ossiform prints bone substitutes using β-TCP ceramics 10:12 The long road to FDA clearance and U.S. market entry 14:03 Why Ossiform moved away from personalized implants 18:26 Listening to surgeons changed everything 23:47 Flatfoot reconstruction and Ossiform’s first clinical products 30:18 Fundraising, commercialization, and building a MedTech startup 38: 54 The hidden decision-makers in healthcare adoption 46:31 The future of bone regeneration, AI, and point-of-care manufacturing Show notes: https://3dheals.com/episode-117-monica-wellejus-the-road-to-3d-printed-bone/ YouTube link:  https://youtu.be/E8t35WzV7Eg?si=QH-XHfJDwihvqv6n Send us Fan Mail Support the show Subscribe to our premium version and support the show.  Follow us: Twitter  Instagram Linkedin 3DHEALS Website Facebook Facebook Group Youtube channel About Pitch3D

    Episode#117| Monica Wellejus:The Road to 3D-Printed Bone

  8. Jun 4

    Episode #115| Professor Paul Dalton: Inventing Melt Electrowriting and the Future of Biofabricationrication

    What does it take to invent a technology that didn't exist before? In this episode, host Dr. Jenny Chen sits down with Professor Paul Dalton, the inventor of melt electrowriting (MEW) and one of the rare "triple threats" in science: an inventor, educator, and futurist. This is also a conversation about science, creativity, and why MEW isn't just a technology but a movement. Paul takes us from a boredom-filled childhood on a rural farm outside Perth, Australia, to the ophthalmic research lab where he helped build artificial corneas that restored sight to blind patients. He shares the moment a failing electrospinning experiment pushed him toward MEW instead — and the "breathless" discovery under the microscope that became MEW. Along the way, Jenny and Paul explore: What electrospinning and melt electrowriting actually are, explained in plain languageWhy MEW pulls fibers instead of pushing them, and how it prints at one-tenth of a teardrop per hourThe decades-long pursuit of clinical applicationsThe open-source "MEWron" printer is bringing MEW to labs for a fraction of the cost of commercial machinesThe two kinds of makers — builders vs. users — and where the community is headingPaul's advice for clinicians and newcomers entering biofabricationPlus, a remarkable offer for listeners at the end of this episode.  🔗 Show notes YouTube recording: Coming soon Send us Fan Mail Support the show Subscribe to our premium version and support the show.  Follow us: Twitter  Instagram Linkedin 3DHEALS Website Facebook Facebook Group Youtube channel About Pitch3D

    Episode #115| Professor Paul Dalton: Inventing Melt Electrowriting and the Future of Biofabricationrication
See All (45)

Ratings & Reviews

5
out of 5
2 Ratings

About

Welcome to the Lattice podcast, the official podcast for 3DHEALS. This is where you will find fun but in-depth conversations (by founder Jenny Chen) with technological game-changers, creative minds, entrepreneurs, rule-breakers, and more. The conversations focus on using 3D technologies, like 3D printing and bioprinting, AR/VR, and in silico simulation, to reinvent healthcare and life sciences. This podcast will include AMA (Ask Me Anything) sessions, interviews, select past virtual event recordings, and other direct engagements with our Tribe.While there is no rule for our podcast content, the only rule we follow is to provide our listeners with a maximized return on their attention and time investment.Follow us on Facebook, Twitter, and Instagram @3dheals, and check out the links in the show notes. 3DHEALS Links: https://linktr.ee/3dheals 🛑 Disclaimer The content of this podcast is for informational and educational purposes only and does not constitute medical, legal, or financial advice. The views and opinions expressed by the host and guests are their own and do not necessarily reflect those of their employers, affiliates, or any associated organizations. While we discuss emerging technologies in healthcare and 3D printing, listeners should consult qualified professionals before making decisions based on the information shared. The mention of specific companies, products, or technologies does not imply endorsement. This podcast may reference early-stage innovations and concepts that are not yet FDA-approved or commercially available. Always follow regulatory guidelines and ethical standards when applying new technologies in clinical or professional settings.

Information